Status:
UNKNOWN
Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer
Lead Sponsor:
Liaquat University of Medical & Health Sciences
Conditions:
Breast Cancer
Eligibility:
All Genders
Brief Summary
Null hypothesis: Histological grade of tumour bears no relation with the status of sex hormone receptors. Alternate hypothesis: Both the histological grade of tumour and expression of sex steroid rec...
Detailed Description
Breast cancer accounts for the largest number of deaths amongst the female population worldwide. It is now considered as a systemic disease even if diagnosed at an initial stage, as the clinical behav...
Eligibility Criteria
Inclusion
- All patients diagnosed with breast cancer irrespective of age, gender and clinical stage
Exclusion
- Any patient who lost to follow up
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 15 2021
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT04707287
Start Date
July 1 2020
End Date
January 15 2021
Last Update
January 14 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fazila Hashmi
Jāmshoro, Sindh, Pakistan
2
Liaquat University of Medical and Health Sciences
Jāmshoro, Pakistan, 76090